An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum

References

• Benson M. Amyloidosis. The Metabolic and Molecular Bases of Inherited Disease, C R Scriver, A L Beaudet, S S William, D Valle. McGraw-Hill, New York 1995; 4159–4191
   Google Scholar
• Kanda Y, Goodman D S, Canfield R E, Morgan F J. The amino acid sequence of human plasma prealbumin. J Biol Chem 1974; 249: 6796–6805
   PubMed Web of Science ®Google Scholar
• Blake C C, Geisow M J, Swan I D, Rerat C, Rerat B. Structure of human plasma prealbumin at 2–5 A resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J Mol Biol 1974; 88: 1–12
   PubMed Web of Science ®Google Scholar
• Connors L H, Richardson A M, Theberge R, Costello C E. Tabulation of transthyretin (TTR) variants as of 1/1/ 2000. Amyloid Int J Clin Exp Invest 2000; 7: 54–69
   PubMed Web of Science ®Google Scholar
• Saraiva M J. Transthyretin mutations in hyper-thyroxinemia and amyloid diseases. Hum Mutat 2001; 17: 493–503
   PubMed Web of Science ®Google Scholar
• Theberge R, Connors L H, Skinner M, Costello C E. Detection of transthyretin variants using immunoprecipita-tion and matrix-assisted laser desorptioniionization bioreactive probes: a clinical application of mass spectrometry. J Am Soc Mass Spectrom 2000; 11: 172–175
   PubMedGoogle Scholar
• Wada Y, Matsuo T, Katakuse I, Suzuki T, Azuma T, Tsujino S, Kishimoto S, Matsuda H, Hayashi A. Mass spec-trometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy. Biochim Biophys Acta 1986; 873: 316–319
   PubMedGoogle Scholar
• Lim A, Prokaeva T, McComb M E, O'Connor P B, Theberge R, Connors L H, Skinner M, Costello C E. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem 2002; 74: 741–751
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Okamoto N, Tanaka K, Shimizu A. Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: a unique simple method to identify molecular weight variants. Biol Mass Spectrom 1994; 23: 230–233
   PubMedGoogle Scholar
• Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A, Nakazato M, Kangawa K, Matsuo H. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatographyielectrospray ionization mass spectrometry using material precipitated with specific antiserum. J Mass Spectrom 1996; 31: 112–114
   PubMed Web of Science ®Google Scholar
• Theberge R, Connors L, Skinner M, Skare J, Costello C E. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorptioniionization mass spectrometry. Anal Chem 1999; 71: 452–459
   PubMed Web of Science ®Google Scholar
• Bergen H R, Lacey J M, O'Brien J F, Naylor S. Online single-step analysis of blood proteins: the transferrin story. Anal Biochem 2001; 296: 122–129
   PubMedGoogle Scholar
• Lacey J M, Bergen H R, Magera M J, Naylor S, O'Brien J F. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem 2001; 47: 513–518
   PubMed Web of Science ®Google Scholar
• Naylor S, Abraham R, Bradwell R A, Fonseca R, Katzmann J, Kyle R A, Bergen H R. Analysis of immunoglo-bulin light chains in primary amyloidosis-direct on-line assay for amy loidogenic kappa and lambda light chains directly from serum. Proceedings of the IXth Symposium on Amyloidosis, BudapestHungary, 2001
   Google Scholar
• Sen J W, Bergen H R, 3rd, Heegaard N H. On-line immunoaffinity-liquid chromatography-mass spectrometry for identification of amyloid disease markers in biological fluids. Anal Chem 2003; 75: 1196–1202
   PubMed Web of Science ®Google Scholar
• Nakazato M, Kangawa K, Minamino N, Tawara S, Matsuo H, Araki S. Identification of a prealbumin variant in the serum of a Japanese patient with familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 1984; 122: 712–718
   PubMedGoogle Scholar
• Connors L H, Ericsson T, Skare J, Jones L A, Lewis W D, Skinner M. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta 1998; 1407: 185–192
   PubMed Web of Science ®Google Scholar
• Altland K, Winter P, Sauerbom M K. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 1999; 20: 1349–1364
   PubMed Web of Science ®Google Scholar
• Nelis E, Warner L E, Vriendt E D, Chance P F, Lupski J R, Van Broeckhoven C. Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot-Marie-Tooth type 1 disease and related peripheral neuropathies. Eur J Hum Genet 1996; 4: 329–333
   PubMed Web of Science ®Google Scholar
• Yamashita T, Ando Y, Bemt Suhr O, Nakamura M, Sakashita N, Ohlsson P I, Terazaki H, Obayashi K, Uchino M, Ando M. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP). J Neurol Sci 2000; 173: 154–159
   PubMed Web of Science ®Google Scholar
• Ando Y, Tashima K, Tanaka Y, Nakazato M, Ericzon B G, Duraj F F, Sakashita N, Kimura E, Ando E, Yonehara T, et al. Treatment of a Japanese patient with familial amyloidotic polyneuropathy with orthotopic liver transplantation. Intern Med 1994; 33: 730–732
   PubMedGoogle Scholar
• Bergethon P R, Sabin T D, Lewis D, Simms R W, Cohen A S, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944–951
   PubMed Web of Science ®Google Scholar
• Suhr O B, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj F F, Groth C G, Ericzon B G. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60: 933–938
   PubMed Web of Science ®Google Scholar
• Ando Y, Ohlsson P I, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sandgren O, Uchino M, Ando M. A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem Biophys Res Commun 1996; 228: 480–483
   PubMed Web of Science ®Google Scholar
• Ranlov I, Ando Y, Ohlsson P I, Holmgren G, Ranlov P J, Suhr O B. Rapid screening for amyloid-related variant forms of transthyretin is possible by electrospray ionization mass spectrometry. Eur J Clin Invest 1997; 27: 956–959
   PubMed Web of Science ®Google Scholar
• Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li Y F, Masuda Y, Ikeda S. Usefulness of MALDIITOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid Int J Clin Exp Invest 1999; 6: 282–288
   PubMed Web of Science ®Google Scholar
• Bergquist J, Andersen O, Westman A. Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2000; 46: 1293–1300
   PubMed Web of Science ®Google Scholar
• Ando Y, Almeida M, Ohlsson P I, Ando E, Negi A, Suhr O, Terazaki H, Obayashi K, Ando M, Saraiva M J. Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: effects on detection and quantification. Biochem Biophys Res Commun 1999; 261: 264–269
   PubMed Web of Science ®Google Scholar
• Hammarstrom P, Sekijima Y, White J T, Wiseman R L, Lim A, Costello C E, Altland K, Garzuly F, Budka H, Kelly J W. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?. Biochemistry 2003; 42: 6656–6663
   PubMed Web of Science ®Google Scholar
• Sousa M M, Cardoso I, Femandes R, Guimaraes A, Saraiva M J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001; 159: 1993–2000
   PubMed Web of Science ®Google Scholar